11:55 a.m. New York time
Another trigger on my 10% trailing stop/loss, on ESTE in the Momentum Portfolio.
The Genetics Portfolio is up for management today and saw three falls from qualification as Zacks scores moved from “buy” to “hold”. Two symbols were added to genetics.
One symbol, HII, dropped off the Bench due to sliding score.
I re-established two symbols that had been stopped yesterday but still qualified, TLRY to Growth and, outside of the rules, TNK, which had been stopped from the Bench but still has a qualifying score.
The trades:
- Genetics
- Exits
- AQB, for a $2.56 credit, up 53 cents from entry, producing a 26.1% return over 26 days, or a 367% annual rate.
- CGEN, a $5.98 credit, up 2 cents from entry, a 0.3% return over 22 days for a +6% annual rate.
- INO, out for a $3.37 credit, up 25 cents from entry, an 8.0% return over seven days for a +418% annual rate
- Entries
- EDIT for a $31.79 debit
- SYRS for an $8.42 debit
- Exits
- Momentum
- Exits
- ESTE hit the 10% stop/loss and was sold for a $5.64 credit, down $1.39 from entry. The exit produced a 19.7% loss over seven days for a -1,030% annual rate
- Exits
- Growth
- Entry
- TLYS, a position exited January 13 by a trailing 10% stop/loss, re-established for an $8.86 debit.
- Entry
- Bench
- Exit
- HII, formerly of the Growth Portfolio, for a $3.37 credit, up 25 cents from entry, showing a +8.0% return over seven days for a $418% annual rate.
- Entry
- TNK, exited January 13 by a trailing 10% stop/loss, re-established for a $23.79 debit
- Exit
By Tim Bovee, Portland, Oregon, January 14, 2020
You must be logged in to post a comment.